weight stall on tirzepatide Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 Tirzepatide Injections for Medical Weight
Description
All GLP-1 receptor agonists have similar effects and side effects

Although the absolute risk remains low, this association has raised concerns among medical experts and regulatory authorities

When symptoms do occur, they may include: Pelvic pain or discomfort ranging from dull aching to sharp pain, often on one side Bloating or abdominal swelling Pain during intercourse (dyspareunia) Irregular menstrual periods or changes in menstrual flow Difficulty emptying the bladder completely Pressure on the bowel , causing constipation Risk factors for developing ovarian cysts include hormonal imbalances, previous ovarian cysts, endometriosis, pelvic infections, and PCOS
:max_bytes(150000):strip_icc()/VWHealth-When-can-you-expect-a-GLP-1-plateau-edit-2-0d8af747d2004ea18f48ef96fe6c5284.jpg)
In the US, the trajectory took a slightly different turn toward the end of the year

These patients need further specialized assessment for diagnosing cardiac amyloid
